CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease

Open access
Höglinger, Günter U., Breunig, Joshua J., Depboylu, Candan, Rouaux, Caroline, Michel, Patrick P., Alvarez-Fischer, Daniel, Boutillier, Anne-Laurence, DeGregori, James, Oertel, Wolfgang H., Rakic, Pasko, Hirsch, Etienne C., Hunot, Stéphane · 2007 · Proceedings of the National Academy of Sciences

Abstract

The mechanisms leading to degeneration of dopaminergic neurons (DNs) in the substantia nigra of patients with Parkinson's disease (PD) are not completely understood. Here, we show, in the postmortem human tissue, that these neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA. We further demonstrate that the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injected into mice and application of its active metabolite 1-methyl-4-phenylpyridinium to mesencephalic cultures activate the retinoblastoma–E2F pathway in postmitotic DNs. We also find that cell death rather than mitotic division followed the toxin-induced replication of DNA, as determined by BrdU incorporation in DNs. In addition, blocking E2F-1 transcription protected cultured DNs against 1-methyl-4-phenylpyridinium toxicity. Finally, E2F-1-deficient mice were significantly more resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic cell death than their wild-type littermates. Altogether, BrdU incorporation in mature neurons and lack of evidence for newborn neurons argue against neuronal turnover in normal conditions or during pathological states in the substantia nigra. Instead, our results demonstrate that mitosis-like signals are activated in mature DNs in patients with PD and mediate neuronal death in experimental models of the disease. Inhibition of mitosis-like signals may therefore provide strategies for neuroprotection in PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0611671104

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 1

  1. J DeGregori Biochim Biophys Acta 1602, 131–150 (2002).

Cited by

See all 277

Metadata

Authors
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S.
Affiliations
  • Inserm (FR)
  • Yale University (US)
  • Philipps University of Marburg (DE)
  • *Department of Experimental Neurology, Philipps University, 35039 Marburg, Germany;
  • University of Colorado Denver (US)
  • Department of Experimental Neurology and Therapeutics, Unité Mixte de Recherche 679, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France;
Corresponding author
Rakic, Pasko
Venue
Proceedings of the National Academy of Sciences
Published
2007-02-27
Volume
104
Issue
9
Pages
3585-3590
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2092598865
Cited by
276
References
25
Citations by year
2026: 10 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 22 · 2014: 17 · 2013: 19 · 2012: 16
FWCI
16.14
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Commission (LSHM-CT-2003-503330)
  • Bundesministerium für Bildung und Forschung (01GO0201, BMBF-01GN0513, 01GN0513)
  • National Institute of Mental Health (R24MH068855, R24MH68855)
  • National Cancer Institute (R01CA077314)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Parkinson's disease, dopaminergic neurons, substantia nigra, retinoblastoma protein, E2F1, cell cycle, neuronal cell death, MPTP, MPP+, DNA replication, neuroprotection, postmitotic neurons
MeSH terms
Analysis of Variance, Animals, Chromatography, High Pressure Liquid, Gene Expression Regulation, Humans, Immunohistochemistry, Interneurons, Male, Mice, Inbred C57BL, Parkinson Disease, Substantia Nigra, Signal Transduction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Oligonucleotides, Antisense, Apoptosis, In Situ Hybridization, Mice, Knockout, E2F1 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. https://app.cochat.ai/papers/10.1073/pnas.0611671104
The paper
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S. (2007). The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0611671104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.